TKD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Takeda Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 31.86 EUR -1.33%

Market Cap: €50B

T	Takeda Pharmaceutical Co Ltd XHAM:TKD	JP
	Bio-Techne Corp NASDAQ:TECH	US
J	JPMorgan Chase & Co XMUN:CMC	US
S	Standard Chartered PLC F:STD	UK
	Crescent Biopharma Inc F:C68	US
S	Service Corporation International XMUN:SVC	US
A	Abercrombie & Fitch Co XMUN:AFT	US
A	AIA Group Ltd F:7A2	HK
V	Vulcan Materials Co DUS:VMC	US
C	China Citic Bank Corp Ltd XMUN:D7C	CN
M	McCormick & Company Inc F:MCX	US
T	Takeda Pharmaceutical Co Ltd SWB:TKD	JP

Profitability Summary

Takeda Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

68% > 65%

Low Operating Margin

Sustainable 3Y Average Operating Margin

10%

Declining Operating Margin

12% > 3%

Negative Net Margin

-4%

Low 3Y Average Net Margin

Declining Net Margin

5% > -4%

Exceptional Free Cash Flow Margin

11%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.